×
S&P 500   3,785.38
DOW   30,775.43
QQQ   280.28
S&P 500   3,785.38
DOW   30,775.43
QQQ   280.28
S&P 500   3,785.38
DOW   30,775.43
QQQ   280.28
S&P 500   3,785.38
DOW   30,775.43
QQQ   280.28
NASDAQ:SRTS

Sensus Healthcare Stock Forecast, Price & News

$7.68
-0.20 (-2.54%)
(As of 06/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$7.56
$7.96
50-Day Range
$7.06
$9.22
52-Week Range
$3.21
$11.96
Volume
87,300 shs
Average Volume
289,548 shs
Market Capitalization
$128.09 million
P/E Ratio
6.00
Dividend Yield
N/A
Price Target
$13.50
30 days | 90 days | 365 days | Advanced Chart

Receive SRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SRTS Stock Forecast (MarketRank)

Overall MarketRank

2.73 out of 5 stars

Medical Sector

60th out of 1,433 stocks

Surgical & Medical Instruments Industry

7th out of 139 stocks

Analyst Opinion: 3.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 3.1 5 -4 -3 -2 -1 -
Sensus Healthcare logo

About Sensus Healthcare (NASDAQ:SRTS)

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

SRTS Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SRTS
Employees
37
Year Founded
N/A

Company Calendar

Last Earnings
5/05/2022
Today
6/30/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$13.50
High Stock Price Forecast
$14.00
Low Stock Price Forecast
$13.00
Forecasted Upside/Downside
+75.8%
Consensus Rating
Buy
Rating Score (0-4)
3
Research Coverage
2 Analysts

Profitability

Net Income
$4.12 million
Pretax Margin
63.96%

Debt

Sales & Book Value

Annual Sales
$27.04 million
Cash Flow
$0.27 per share
Book Value
$1.57 per share

Miscellaneous

Free Float
12,625,000
Market Cap
$128.09 million
Optionable
Not Optionable
Beta
0.51














Sensus Healthcare Frequently Asked Questions

Should I buy or sell Sensus Healthcare stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Sensus Healthcare stock.
View analyst ratings for Sensus Healthcare
or view top-rated stocks.

What is Sensus Healthcare's stock price forecast for 2022?

2 brokers have issued 12 month price targets for Sensus Healthcare's shares. Their SRTS stock forecasts range from $13.00 to $14.00. On average, they anticipate Sensus Healthcare's share price to reach $13.50 in the next twelve months. This suggests a possible upside of 75.8% from the stock's current price.
View analysts' price targets for Sensus Healthcare
or view top-rated stocks among Wall Street analysts.

How has Sensus Healthcare's stock performed in 2022?

Sensus Healthcare's stock was trading at $7.22 at the beginning of the year. Since then, SRTS shares have increased by 6.4% and is now trading at $7.68.
View the best growth stocks for 2022 here
.

When is Sensus Healthcare's next earnings date?

Sensus Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Sensus Healthcare
.

How were Sensus Healthcare's earnings last quarter?

Sensus Healthcare, Inc. (NASDAQ:SRTS) posted its earnings results on Thursday, May, 5th. The company reported $0.20 EPS for the quarter, topping analysts' consensus estimates of $0.06 by $0.14. The company had revenue of $10.34 million for the quarter, compared to the consensus estimate of $6.24 million. Sensus Healthcare had a trailing twelve-month return on equity of 31.17% and a net margin of 62.07%. During the same period in the previous year, the business earned ($0.07) EPS.
View Sensus Healthcare's earnings history
.

Who are Sensus Healthcare's key executives?

Sensus Healthcare's management team includes the following people:
  • Mr. Joseph C. Sardano, Co-Founder, Chairman & CEO (Age 69, Pay $630.45k) (LinkedIn Profile)
  • Mr. Michael J. Sardano, Pres & Gen. Counsel (Age 33, Pay $273.37k)
  • Mr. Javier Rampolla, Chief Financial Officer (Age 49)
  • Mr. Nicolas Soro, Chief Operating Officer (Age 37)
  • Mr. Yonatan Vainer, Chief Technology Officer (Age 35)
  • Mr. Benson Suen, VP of International Sales
  • Dr. Mark S. Nestor, Medical Director & Member of Medical Advisory Board
  • Dr. Clay Jefferies Cockerell, Clinical Director & Member of Medical Advisory Board (Age 65)

What other stocks do shareholders of Sensus Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI), Sorrento Therapeutics (SRNE), Corbus Pharmaceuticals (CRBP), Nabriva Therapeutics (NBRV), Sangamo Therapeutics (SGMO), Viking Therapeutics (VKTX), Vaxart (VXRT), Amarin (AMRN), Palatin Technologies (PTN) and QUALCOMM (QCOM).

When did Sensus Healthcare IPO?

(SRTS) raised $20 million in an initial public offering on Wednesday, March 30th 2016. The company issued 1,800,000 shares at a price of $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.

What is Sensus Healthcare's stock symbol?

Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS."

How do I buy shares of Sensus Healthcare?

Shares of SRTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sensus Healthcare's stock price today?

One share of SRTS stock can currently be purchased for approximately $7.68.

How much money does Sensus Healthcare make?

Sensus Healthcare (NASDAQ:SRTS) has a market capitalization of $128.09 million and generates $27.04 million in revenue each year. The company earns $4.12 million in net income (profit) each year or $1.279990 on an earnings per share basis.

How many employees does Sensus Healthcare have?

Sensus Healthcare employs 37 workers across the globe.

How can I contact Sensus Healthcare?

Sensus Healthcare's mailing address is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. The official website for Sensus Healthcare is www.sensushealthcare.com. The company can be reached via phone at (561) 922-5808, via email at [email protected], or via fax at 561-948-2071.

This page (NASDAQ:SRTS) was last updated on 7/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.